drug · small molecule
patient view →(decitabine + tetrahydrouridine)
Phase 2updated 2mo agoby Novo Nordisk AS🔗 ChEMBL
Phase 2community read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 6 approved and 34 investigational indications.
targets
DNA (cytosine-5)-methyltransferase 1DNA (cytosine-5)-methyltransferase 3A
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that